Organigram Global (OGI) Interest & Investment Income (2018 - 2021)
Organigram Global (OGI) posted quarterly Interest & Investment Income of -$432000.0 for Q2 2021, down 1185.35% year-on-year from $39802.9 in Q2 2020, and down 274.9% on a QoQ basis from $247000.0 in Q1 2021.
Organigram Global (OGI) Interest & Investment Income (2018 - 2021) Analysis & Trends
Organigram Global (OGI) has reported Interest & Investment Income for 4 consecutive years, with -$432000.0 the latest figure, recorded in Q2 2021.
- Quarterly Interest & Investment Income fell 1185.35% year-over-year to -$432000.0 in Q2 2021, while the trailing twelve-month figure through May 2021 was -$173002.3 (down 126.03% YoY) and the FY2023 annual result came in at $3.0 million, changed N/A from the prior year.
- Interest & Investment Income slipped to -$432000.0 in Q2 2021 per OGI's latest filing, from $247000.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for OGI reached as high as $872879.5 in Q3 2019 and fell as low as -$578000.0 in Q2 2018.
- A 4-year average of -$31542.6 and a median of -$74804.8 in 2020 frame the typical range for Interest & Investment Income.
- The largest YoY upside for Interest & Investment Income was 252.47% in 2021 against a maximum downside of 1185.35% in 2021.
- Year by year, Interest & Investment Income stood at -$578000.0 in 2018, then soared by 251.02% to $872879.5 in 2019, then sank by 113.29% to -$116000.0 in 2020, then slumped by 272.41% to -$432000.0 in 2021.
- According to Business Quant data, Interest & Investment Income over the past three periods registered -$432000.0, $247000.0, and -$116000.0 for Q2 2021, Q1 2021, and Q4 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 32.85 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 41.80 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 28.10 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Organigram Global | 121.15 Mn | 154.23 Mn | 28.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2021 | -432,000.00 |
| Feb 28, 2021 | 247,000.00 |
| Nov 30, 2020 | -116,000.00 |
| Aug 31, 2020 | 127,997.72 |
| May 31, 2020 | -33,609.58 |
| Feb 29, 2020 | -162,000.00 |
| Aug 31, 2019 | 872,879.50 |
| May 31, 2019 | -12,693.45 |
| Feb 28, 2019 | -229,000.00 |
| May 31, 2018 | -578,000.00 |